These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24504502)

  • 21. Long-term ex vivo monitoring of in vivo microRNA activity in liver using a secreted luciferase sensor.
    Wang G; Dong X; Hu J; Tian W; Yuchi J; Wang Y; Wu X
    Sci China Life Sci; 2011 May; 54(5):418-25. PubMed ID: 21574043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of hydrogen sulfide (H
    Wu Y; Guo YY; Zhang YY; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
    Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
    Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β-adrenoceptor regulates miRNA expression in rat heart.
    Hou Y; Sun Y; Shan H; Li X; Zhang M; Zhou X; Xing S; Sun H; Chu W; Qiao G; Lu Y
    Med Sci Monit; 2012 Aug; 18(8):BR309-314. PubMed ID: 22847192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression.
    Wang T; Zhai M; Xu S; Ponnusamy M; Huang Y; Liu CY; Wang M; Shan C; Shan PP; Gao XQ; Wang K; Chen XZ; Liu J; Xie JY; Zhang DY; Zhou LY; Wang K
    Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMGA1 is a new target of miR-195 involving isoprenaline-induced cardiomyocyte hypertrophy.
    You XY; Huang JH; Liu B; Liu SJ; Zhong Y; Liu SM
    Biochemistry (Mosc); 2014 Jun; 79(6):538-44. PubMed ID: 25100012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A.
    Liu K; Hao Q; Wei J; Li GH; Wu Y; Zhao YF
    J Hypertens; 2018 Sep; 36(9):1847-1857. PubMed ID: 29664809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated miRNA-mRNA networks underlie attenuation of chronic β-adrenergic stimulation-induced cardiac remodeling by minocycline.
    Russell JJ; Mummidi S; DeMarco VG; Grisanti LA; Bailey CA; Bender SB; Chandrasekar B
    Physiol Genomics; 2024 Apr; 56(4):360-366. PubMed ID: 38314697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of microRNA-1 on negatively regulating L-type calcium channel beta2 subunit gene expression during cardiac hypertrophy].
    Wu Y; Geng P; Wang YQ; Liu Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2012 Jul; 28(4):304-8. PubMed ID: 23156720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
    Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective Action of Diazoxide on Isoproterenol-Induced Hypertrophy Is Mediated by Reduction in MicroRNA-132 Expression.
    Narasimhan G; Carrillo ED; Hernández A; García MC; Sánchez JA
    J Cardiovasc Pharmacol; 2018 Nov; 72(5):222-230. PubMed ID: 30403388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
    Yang Y; Ago T; Zhai P; Abdellatif M; Sadoshima J
    Circ Res; 2011 Feb; 108(3):305-13. PubMed ID: 21183740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-30e Attenuates Isoproterenol-induced Cardiac Fibrosis Through Suppressing Snai1/TGF-β Signaling.
    Zhang W; Chang H; Zhang H; Zhang L
    J Cardiovasc Pharmacol; 2017 Dec; 70(6):362-368. PubMed ID: 28777253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
    Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
    Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing reporter constructs for in vivo bioluminescence imaging of interferon-γ stimulated mesenchymal stromal cells.
    Perez-Galarza J; Carlotti F; Rabelink MJ; Cramer S; Hoeben RC; Fibbe WE; van Pel M
    Exp Hematol; 2014 Sep; 42(9):793-803.e1. PubMed ID: 24746876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging Dendrimer-Grafted Graphene Oxide Mediated Anti-miR-21 Delivery With an Activatable Luciferase Reporter.
    Wang F; Zhang B; Zhou L; Shi Y; Li Z; Xia Y; Tian J
    ACS Appl Mater Interfaces; 2016 Apr; 8(14):9014-21. PubMed ID: 27010367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.
    Xu XD; Song XW; Li Q; Wang GK; Jing Q; Qin YW
    J Cell Physiol; 2012 Apr; 227(4):1391-8. PubMed ID: 21618527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.